Barriers to and Facilitators of Artificial Intelligence Adoption in Health Care: Scoping Review

Background: Artificial intelligence (AI) use cases in health care are on the rise, with the potential to improve operational efficiency and care outcomes. However, the translation of AI into practical, everyday use has been limited, as its effectiveness relies on successful implementation and adoption by clinicians, patients, and other health care stake holders. Objective: As adoption is a key factor in the successful proliferation of an innovation, this scoping review aimed at presentingan overview of the barriers to and facilitators of AI adoption in health care. Methods: A scoping review was conducted using the guidance provided by the Joanna Briggs Institute and the framework proposed by Arksey and O'Malley. MEDLINE, IEEE Xplore, and ScienceDirect databases were searched to identify publication sin English that reported on the barriers to or facilitators of AI adoption in health care. This review focused on articles published between January 2011 and December 2023. The review did not have any limitations regarding the health care setting (hospitalor community) or the population (patients, clinicians, physicians, or health care administrators). A thematic analysis was conducted on the selected articles to map factors associated with the barriers to and facilitators of AI adoption in health care. Results: A total of 2514 articles were identified in the initial search. After title and abstract reviews, 50 (1.99%) articles wereincluded in the final analysis. These articles were reviewed for the barriers to and facilitators of AI adoption in health care. Mostarticles were empirical studies, literature reviews, reports, and thought articles. Approximately 18 categories of barriers andfacilitators were identified. These were organized sequentially to provide considerations for AI development, implementation, and the overall structure needed to facilitate adoption. Conclusions: The literature review revealed that trust is a significant catalyst of adoption, and it was found to be impacted byseveral barriers identified in this review. A governance structure can be a key facilitator, among others, in ensuring all the elementsidentified as barriers are addressed appropriately. The findings demonstrate that the implementation of AI in health care is still, in many ways, dependent on the establishment of regulatory and legal frameworks. Further research into a combination of governance and implementation frameworks, models, or theories to enhance trust that would specifically enable adoption is needed to provide the necessary guidance to those translating AI research into practice. Future research could also be expanded to include attempts at understanding patients' perspectives on complex, high-risk AI use cases and how the use of AI applications affects clinical practice and patient care, including sociotechnical considerations, as more algorithms are implemented in actual clinical environments.